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A B S T R A C TObjective: To estimate the relationship between health utilities and
body mass index (BMI) among a cohort of obese patients who under-
went laparoscopic adjustable gastric banding (LAGB). Methods: We
used a cross-sectional survey to ascertain demographic, clinical, and
health utility data from patients who had undergone LAGB in
Washington State from 2004 to 2010. The EuroQol ﬁve-dimensional
(EQ-5D) questionnaire was used for health utility estimation. We
calculated adjusted EQ-5D questionnaire indices across BMI categories
by using a two-part model. We also used logistic regression to
examine the relationship between BMI and the likelihood of reporting
problems on each of the EQ-5D questionnaire dimension. Results:
Data were obtained from 790 subjects. The mean adjusted EQ-5D
questionnaire indices for all obese BMI categories were signiﬁcantly
lower than those in the normal weight category. The relationship
between BMI and EQ-5D questionnaire indices was nonlinear.
Respondents classiﬁed as morbidly obese II (BMI 4 50 kg/m2) had
the greatest decrement (−0.15, 95% conﬁdence interval −0.28 to −0.01)see front matter Copyright & 2013, International S
r Inc.
1016/j.jval.2013.05.001
.washington.edu.
ndence to: Sean D. Sullivan, Pharmaceutical Outcom
ortheast Paciﬁc Avenue, H-375Q, Box 357630, Seain EQ-5D questionnaire indices. The association between EQ-5D
questionnaire indices and BMI at the time of the survey was weaker
after adjusting for weight loss after LAGB. Respondents with higher
BMI were more likely to report having problems in the mobility, usual/
activity, pain/discomfort, and anxiety/depression dimensions (trend
test, Po 0.05), but not for the self-care dimension (trend test, P ¼ 0.08).
Conclusions: The EQ-5D questionnaire has a negative and nonlinear
relationship with BMI for obese patients who had LAGB. The relationship
is confounded by weight loss. Within the EQ-5D questionnaire dimen-
sions, patients are more likely to report having problems in the mobility,
usual/activity, pain/discomfort, and anxiety/depression dimensions in
higher BMI categories, but not in the self-care dimension.
Keywords: EQ-5D, gastric banding, health-related quality of life, health
utility, obesity.
Copyright & 2013, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Background
Laparoscopic adjustable gastric banding (LAGB) is a minimally
invasive bariatric surgery for treating obesity. The procedure
has increased in popularity from 1% of bariatric operations
in 2004 to 29% in 2008 [1]. While weight loss is an important
clinical outcome following bariatric surgery, patient-reported
outcomes, such as health utility and health-related quality of
life (HRQOL), are gaining traction, particularly for reimbursement
decisions [2,3].
Despite the frequent use of health utility assessments in
studies of obese patients, a number of gaps remain. First,
although studies have measured health utilities by using the
EuroQol ﬁve-dimensional (EQ-5D) questionnaire multiattri-
bute utility index among obese patients [4–8], there is a
paucity of data for people who are morbidly obese (body mass
index [BMI] 4 40 kg/m2). A common issue is that researchers
have grouped obese and morbidly obese individuals into a
single category, potentially introducing misclassiﬁcation intheir analyses [5–9]. A recent study has shown the statistical
impact of grouping morbidly obese patients into a single
category on mortality estimates [10]. To estimate health
utility values for morbidly obese individuals, Campbell et al.
[11] performed a linear regression to extrapolate health util-
ities for morbidly obese and super obese people. It is unclear,
however, whether such linear extrapolation provides ideal
health utility estimates.
Few studies have described the relationship between health
utility, BMI, and the magnitude of BMI changes after bariatric
surgery. Most importantly, none of the studies was conducted on
obese patients who underwent LAGB. One published study used a
hypothetical scenario to elicit how patients might value weight
change in terms of patient preferences, but it did not assess
actual health state preference or health utility following weight
loss [12,13].
The goal of this study was to estimate the relationship
between EQ-5D questionnaire indices and the BMI among a
cohort of obese patients who underwent LAGB. Second, weociety for Pharmacoeconomics and Outcomes Research (ISPOR).
es Research and Policy Program, University of Washington School
ttle, WA 98195, USA.
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of the EQ-5D questionnaire and each obesity category.Methods
Data Collection
A cross-sectional survey [14] was created to collect data from
patients who had LAGB surgery in Washington State from year
2004 to 2010. The survey contained the EQ-5D-3L questionnaire
instrument [15] and questions on patients’ demographics, height,
weight, weight change since surgery, obesity-related comorbid-
ities, insurance status, and type of band used. Comorbidities were
ascertained by directly asking respondents whether they have
obesity-related diseases (diabetes, hypertension, sleep apnea,
urinary incontinence) or use any interventions to manage
obesity-related conditions (i.e., home mobility device). Eligible
participants were patients aged 18 years or older who had under-
gone LAGB at inpatient or outpatient surgical centers in Wash-
ington State. Surgical sites within Washington State performing
LAGB were identiﬁed and recruited by contacting the surgeons
who performed LAGB. Once a surgical site agreed to participate,
patients eligible to receive mailing were identiﬁed. Patients were
contacted by mail with the request to complete the survey. Each
subject was assigned an ID for data entry. Round one of the survey
mailing started in January 2010, which included a $2 monetary
incentive and the survey. Additional rounds of the survey were
sent out to patients who did not respond. In the end, a total of ﬁve
rounds of the survey were completed. In addition, we separately
obtained deidentiﬁed age information of the respondents at the
time of surgery from the surgical sites. Approval from the
University of Washington Institutional Review Board was obtained
before the beginning of the data collection process.
Classiﬁcations of BMI Categories
We calculated the BMI by using respondents’ self-reported height
and weight measures. To compare EQ-5D questionnaire indices
across BMI categories, we adopted the World Health Organization
BMI classiﬁcations [16], with further stratiﬁcation of the class III
obesity into two additional morbid obesity categories. The categories
included normal weight (BMI 19–24.99 kg/m2), overweight (BMI 25–
29.99 kg/m2), class I obesity (BMI 30–34.99 kg/m2), class II obesity (BMI
35–39.99 kg/m2), class III obesity (BMI 40–44.99 kg/m2), morbid obesity
I (BMI 45–49.99 kg/m2), and morbid obesity II (BMI 4 50 kg/m2). BMI
change was calculated by subtracting BMI before (baseline) LAGB
surgery from BMI at the time of the survey (after LAGB surgery).
Valuation of EQ-5D Questionnaire Indices
The EQ-5D-3L questionnaire is a HRQOL instrument containing
ﬁve dimensions (mobility, self-care, usual/activity, pain/discom-
fort, and anxiety depression) and a visual analogue scale. Each
dimension has three severity levels: no problem, some problem,
and severe problem. The responses to the ﬁve dimensions allow
patients to be classiﬁed into 243 health states. To transform these
health states into US population-based health preference
weights, or health utilities, we used the valuation method of
Shaw et al. [17], which asked the study respondents to value 13 of
the 243 possible health states by using the time trade-off method.
The EQ-5D questionnaire index measures health utility on a scale
between 0 (death) and 1 (perfect health).
Descriptive Analysis
Descriptive statistics were used to describe respondents’ age, gen-
der, insurance status, presurgical BMI, BMI at the time of the survey,comorbidities, and the type of band used. Mean EQ-5D questionnaire
indices were stratiﬁed by BMI categories and BMI changes.
Main Analysis
We ﬁrst examined the relationship between BMI and EQ-5D
questionnaire indices among patients who underwent LAGB.
The dependent variable was the EQ-5D questionnaire index,
and the primary independent variable was BMI at the time of
the survey, coded as dummy variables according to World Health
Organization BMI categories, with normal weight as the reference
category. We adjusted for time since surgery, gender, insurance
status, and the number of comorbidities. We were not able to
adjust for age because age data were not linked to respondent
surveys. Inspection of the distribution of EQ-5D questionnaire
indices graphically showed that a high proportion of respondents
had values of 1 and was left skewed (ceiling effects) [18,19]. When
EQ-5D questionnaire data are nonnormal and exhibit ceiling
effects, the standard linear model may yield inaccurate estimates
regarding the relationship with BMI. We thus used a two-part
model (TPM), which is a more ﬂexible approach to address the
ceiling effect and the left-skewed distribution. It had also been
demonstrated that the TPM performed better than other models
including censored least absolute deviation models or Tobit
models in addressing ceiling effects of EQ-5D questionnaire data
[19,20]. To estimate the TPM, we ﬁrst used a logistic model to
estimate the probability that EQ-5D questionnaire values were 1.
We then used a generalized linear model with the log link
function and Gaussian distribution to model EQ-5D questionnaire
indices not equal to 1 to address the skewed distribution. The use
of the generalized linear model also avoids potential difﬁculties
of retransformation of the dependent variable [21]. The expected
value of EQ-5D questionnaire indices for a given BMI category
was then calculated by multiplying the probability of EQ-5D
questionnaire indices not at 1 and the expected EQ-5D question-
naire indices given EQ-5D indices were not equal to 1. We also
calculated marginal effects for each BMI category, which indi-
cated the difference in EQ-5D questionnaire values for a given
category relative to the normal and to the adjacent weight
category. Ninety-ﬁve percent conﬁdence intervals for marginal
effects were estimated by bootstrapping (500 replications) [22].
Additional Analyses
To examine how weight change impacted the relationship
between BMI and the EQ-5D questionnaire, we performed two
additional analyses. First, we added BMI change as an additional
covariate to determine whether it confounded the relationship
between BMI and the EQ-5D questionnaire index. In addition, to
examine the relationship between BMI and the likelihood of
reporting problems on each of the EQ-5D questionnaire dimen-
sions, we constructed ﬁve separate multiple logistic regression
models for each of the ﬁve dimensions, adjusting for time since
surgery, gender, insurance status, and the number of comorbid-
ities. We dichotomized dependent variables by recoding EQ-5D
questionnaire dimension measures as 0 for no problem and 1 for
some problem or severe problem. We used the chi-squared test of
trend to examine for association between the likelihood of
reporting problems in each dimension as BMI. An alpha level of
0.05 was used to assess statistical signiﬁcance. All statistical
analyses were performed by using STATA 12.1 (StataCorp, College
Station, TX).Results
A total of 1556 surveys were distributed, and 790 surveys were
returned (50.77% response rate). The mean time between surgery
Table 1 – Responders’ characteristics.
Characteristics Value Number of
respondents*
Age (y), mean  SD 48.9  10.9 720
Gender (%)
Female 81.10 639/787
Male 18.80 148/787
Health insurance
coverage (%)
Yes 70.60 555/786
No 29.30 231/786
Mean time since surgery
(mo)
33.65  11.43 745
Mean BMI (presurgical)
(kg/m2)
44.82  7.59 779
Mean BMI (postsurgical)
(kg/m2)
35.07  7.78 779
Comorbidities at the
time of the survey (%)
Immobility 3.09 744
Hypertension 27.09 753
Diabetes 11.55 753
Sleep apnea 20.94 745
Urinary incontinence 9.55 733
Type of band (%)
Lap-Band 83.10 488/587
Ethicon Realize Band 5.90 35/587
Does not know 10.90 64/587
BMI, body mass index.
 Total response rate: 790/1556 ¼ 50.77%.
Table 2 – BMI at the time of the survey and the
EQ-5D questionnaire index.
BMI at the time of
the survey
Mean  SD
EQ-5D
questionnaire
index
Months
since
surgery
Normal weight (n ¼ 45) 0.94  0.10 34.07  9.80
Overweight (n ¼ 160) 0.92  0.10 34.93  12.15
Class I obesity (n ¼ 204) 0.89  0.13 33.15  12.30
Class II obesity (n ¼ 161) 0.84  0.17 32.53  9.45
Class III obesity (n ¼ 108) 0.82  0.17 32.52  12.09
Morbid obesity I (n ¼ 40) 0.80  0.17 35.62  11.60
Morbidy obesity II
(n ¼ 31)
0.70  0.21 35.64  11.08
BMI, body mass index; EQ-5D, EuroQol ﬁve-dimensional.
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female. The mean presurgical height, weight and BMI were 1.68
m, 126.70 kg, and 44.82 kg/m2, respectively. Mean BMI reduction
was 21.41%, mean excess weight loss was 42.50%, and mean
postsurgical BMI at the time of the survey was 35.21 kg/m2. Most
respondents had health insurance coverage at the time of surgery
(70.60%). A total of 83.10% of the respondents received Lap-Band,
5.90% received the Ethicon Realize Band, and 10.90% did not
know which band was placed.Table 3 – EQ-5D Questionnaire index for each BMI categor
Normal
weight
(n ¼ 45)
Overweight
(n ¼ 160)
Class I
obesity
(n ¼ 204
440% reduction 0.96  0.07 0.91  0.09 0.88  0.1
n 20 22 10
39.9%–30% reduction 0.94  0.16 0.94  0.08 0.93  0.0
n 15 57 38
29.9%–20% reduction 0.92  0.09 0.92  0.12 0.88  031
n 9 57 90
19.9%–10% reduction 0.84  0.00 0.89  0.15 0.88  0.1
n 1 21 55
9.9%–0% reduction . 0.92  0.13 0.82  0.2
n 0 3 8
Weight gainer . . .
n 0 0 0
BMI, body mass index; EQ-5D, EuroQol ﬁve-dimensional.Unadjusted Results
EQ-5D questionnaire indices were decreasing with BMI (Table 2).
The normal weight category had the highest EQ-5D questionnaire
index (0.94  0.10), while the morbid obesity II (BMI 4 50 kg/m2)
category had the lowest EQ-5D questionnaire index (0.70  0.21).
In the contingency table (Table 3), both lower BMI at the time of
the survey and higher BMI % change were associated with a
higher EQ-5D questionnaire index.
The proportion of respondents reporting problems on all ﬁve
dimensions of the EQ-5D questionnaire increased with BMI
(Fig. 1). The largest difference in the proportion of patients
reporting problems across BMI categories was in the mobility
and pain/discomfort domains. The proportion of patients report-
ing severe problems was highest in the pain/discomfort and
anxiety/depression domains.
Adjusted EQ-5D Questionnaire Indices from TPMs
The adjusted EQ-5D questionnaire index was negatively associ-
ated with BMI categories at the time of the survey (Table 4). The
mean adjusted EQ-5D questionnaire indices for all BMI categories
classiﬁed as obese were signiﬁcantly lower than those in the
normal weight category at the time of the survey. However, they at the time of the survey stratiﬁed by BMI change %.
Mean  SD
)
Class II
obesity
(n ¼ 161)
Class III
obesity
(n ¼ 108)
Morbid
obesity I
(n ¼ 40)
Morbid
obesity II
(n ¼ 31)
9 1  0.00 . . .
2 0 0 0
8 0.93  0.09 0.58  0.30 . 0.81  0.00
16 2 0 1
5 0.85  0.17 0.87  0.17 0.91  0.12 0.82  0.02
33 19 5 2
2 0.86  0.16 0.87  0.14 0.87  0.11 0.62  0.20
76 50 13 8
4 0.78  0.16 0.74  0.17 0.75  0.17 0.76  0.23
29 31 12 8
0.50  0.22 0.76  0.16 0.71  0.23 0.69  0.21
5 6 10 12
Fig. 1 – Proportion of respondents reporting having problems in ﬁve dimensions of the EQ-5D questionnaire by obesity
severity. EQ-5D, EuroQol ﬁve-dimensional.
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(Table 5). The relationship was negative between normal weights
versus overweight, overweight versus class I obesity, class I
obesity versus class II obesity, and class III obesity versus morbid
obesity I. The marginal effects were −0.027 (−0.073 to 0.018),
−0.031 (−0.050 to 0.023), −0.047 (−0.071 to −0.034), and −0.016
(−0.010 to −0.019), respectively. The marginal effects changed
direction and became positive for class II obesity versus class III
obesity (0.024, 0.014–0.036). Finally, the largest marginal effect
was between morbid obesity I versus morbid obesity II (−0.052,
−0.001 to −0.102). The association between EQ-5D questionnaire
indices and BMI at the time of the survey was substantiallyTable 4 – Marginal effects of EQ-5D questionnaire index
models.
Variables E
Model 1*
Marginal effects 95%
BMI at the time of the survey
by obesity class
Normal weight Base Ba
Overweight −0.027 −0.073 t
Class I obesity −0.058‡ −0.120 t
Class II obesity −0.105‡ −0.193 t
Class III obesity −0.081‡ −0.159 t
Morbid obesity I −0.097‡ −0.178 t
Morbid obesity II −0.149‡ −0.280 t
Note. 95% CIs were estimated by using bootstrapping (500 replications).
dimensional; LABG, adjustable laparoscopic gastric banding.
 Adjusted for months since surgery, gender, insurance status, and num
† Adjusted for months since surgery, gender, insurance status, number
‡ Statistically signiﬁcant based on 95% CI.weakened after adjusting for BMI change. Marginal effects for all
BMI categories were not statistically signiﬁcant after the adjust-
ment (Table 4).
Respondents were more likely to report having problems in
the mobility, usual/activity, pain/discomfort, and anxiety/depres-
sion dimensions in higher BMI categories (Table 6) (trend test, Po
0.05), except for self-care (trend test, P ¼ 0.08), after covariate
adjustment. Among the respondents in the morbid obesity II
category, respondents were most likely to report having problems
in the mobility domain (odds ratio 19.13; 95% conﬁdence interval
6.46–62.58; P o 0.05) and less likely to report problems in the
anxiety/depression domain (odds ratio 1.82; 95% conﬁdencefor different BMI categories after LAGB from two-part
Q-5D questionnaire index
Model 2†
CI Marginal effects 95% CI
se Base Base
o 0.018 −0.028 −0.075 to 0.018
o −0.003 −0.047 −0.118 to 0.024
o −0.038 −0.057 −0.156 to 0.040
o −0.002 −0.041 −0.153 to 0.070
o −0.017 −0.010 −0.128 to 0.106
o −0.018 −0.129 −0.646 to 0.388
BMI, body mass index; CI, conﬁdence interval; EQ-5D, EuroQol ﬁve-
ber of comorbidities.
of comorbidities, and BMI change.
Table 5 – Marginal effects of EQ-5D questionnaire index for different BMI categories after LAGB.
NW vs. OW OW vs. class
I obesity
Class I obesity
vs. class II
obesity
Class II obesity
vs. class III
obesity
Class III
obesity vs.
MO I
MO I vs. MO II
Estimated mean
difference* −0.027 −0.031 −0.047
† 0.024 −0.016† −0.052†
95% CI −0.073 to 0.018 −0.050 to 0.023 −0.071 to −0.034 0.014–0.036 −0.010 to −0.019 −0.001 to −0.102
Note. 95% CIs were estimated by using bootstrapping (500 replications). BMI, body mass index; CI, conﬁdence interval; EQ-5D, EuroQol ﬁve-
dimensional; LABG, adjustable laparoscopic gastric banding; MO I, morbid obesity I; MO II, morbid obesity II; NW, normal weight; OW,
overweight.
 Adjusted for months since surgery, gender, insurance status, and number of comorbidities.
† Statistically signiﬁcant based on 95% CI.
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(BMI 25–30 kg/m2).Discussion
We set out to estimate the relationship between BMI and changes
in BMI and health utilities among individuals who underwent
LAGB. We found that the EQ-5D questionnaire had a negative and
nonlinear association with respondents’ BMI categories, which
remained statistically signiﬁcant after adjusting for gender, time
since surgery, and the number of comorbidities. Adjusting for BMI
change, however, moderated the association. Second, we found
that the pain/discomfort dimension was most strongly associ-
ated with BMI, while the self-care dimension was the least
impacted. We further found that respondents were more likely
to report having problems in four out of the ﬁve dimensions
(mobility, self-care, usual/activity, and pain/discomfort) of the
EQ-5D questionnaire as the BMI increased. The likelihood was
especially high among patients in morbid obesity II category.
Many previous studies have identiﬁed associations between
obesity and lower HRQOL, which is also linked to lower health
utility [23–27]. These studies, however, have a number of limi-
tations. For example, in an economic analysis of gastric bypass
surgery, a prior study assumed that a person who reached a given
BMI level through weight reduction after bariatric surgery had the
same health utility as a patient with the same BMI that was
stable over time and who did not have surgery [27]. They thenTable 6 – Logistic regression of each EQ-5D questionnair
EQ-
Mobility* Self-care*
Variables
OR P OR P
BMI at the time of the survey
Overweight Base† Base
Class I obesity 1.80 0.21 1.57 0.71
Class II obesity 3.69 o0.05 2.59 0.42
Class III obesity 4.95 o0.05 11.31 o0.05
Morbid obesity I 11.71 o0.05 3.50 0.38
Morbid obesity II 19.13 o0.05 16.66 o0.05
BMI, body mass index; EQ-5D, EuroQol ﬁve-dimensional; OR, odds ratio.
 Adjusted for months since surgery, gender, insurance status, number
† Trend test P o 0.05.used linear regression model to estimate health utility values for
patients at different BMI categories. As we have shown in this
study, health utility is associated with not only BMI at the time of
the survey but also the magnitude of BMI change after surgery.
A second limitation of many prior studies was to group
patients with BMI of more than 40 as one category and assumed
that the health utilities were the same within the category
[5,6,9,28]. This approach might be prone to misclassiﬁcation by
not separating those who are in the morbid obesity I (BMI 45–
49.99 kg/m2) and morbid obesity II category (BMI 4 50 kg/m2). In
this study, we were able to differentiate those who have BMI over
40 kg/m2 in three categories (class III obesity, morbid obesity I,
and morbid obesity II) and found that the marginal effects for
these BMI categories were different. In a study by Maheswaran
et al. [28], they reported a reduction in EQ-5D questionnaire
scores by 0.076 from classes I to II obesity to class III obesity (or
−0.124 relative to normal weight). This is in contrast to our
ﬁnding, which showed that starting from class II obesity until
morbid obesity I, the differences are not pronounced, and not
necessarily in a negative trend. As in this study, the most drastic
decrement in EQ-5D questionnaire indices occurs at morbid
obesity II. The fact that few studies have had sufﬁcient numbers
of observations to study the EQ-5D questionnaire indices at the
extreme BMI categories underscores the value of this study,
which was based on a naturally obese population that required
LAGB. Previous studies have also routinely used linear regression
models [5,6,8,11] to estimate the association between EQ-5D
questionnaire indices and BMI. As we mentioned previously,e dimension and BMI at the time of the survey.
5D Questionnaire dimensions
Usual
activity*
Pain/
discomfort*
Anxiety/
depression*
OR P OR P OR P
Base† Base† Base†
1.12 0.83 1.49 0.12 1.19 0.48
3.66 o0.05 1.71 0.05 1.57 0.19
5.80 o0.05 2.74 o0.05 1.91 o0.05
10.93 o0.05 2.46 o0.05 1.43 0.38
10.01 o0.05 5.03 o0.05 1.82 0.18
of comorbidities.
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questionnaire data are nonnormal and exhibit ceiling effects.
We addressed the issue on nonlinearity in the distribution of EQ-
5D questionnaire indices by using a TPM, which has been
previously shown to have a better performance [19]. We recog-
nize, however, that other modeling methods have been studied,
and each of the proposed methods, including the TPM, has
advantages and limitations [18,28–30]. In the end, if EQ-5D
questionnaire modeling is used to generate utility values for
decision making, model choice become critical and a conserva-
tive approach might be necessary.
The EQ-5D questionnaire has been used extensively to esti-
mate health utility for many diseases. Prior studies suggest that a
difference of 0.05 to 0.08 (disutility) in the EQ-5D questionnaire
index is considered clinically and economically meaningful
[31,32]. In our analysis, those who had a BMI of higher than 30
kg/m2 at the time of the survey (class I obesity-morbid obesity II)
reached this meaningful difference than did those in the normal
weight category. In other disease areas, a 0.05 to 0.08 disutility in
the EQ-5D questionnaire index can be seen in those with affective
psychosis, depression, heart failure, or stroke [33]. Furthermore,
we found those who are in morbidly obese II category to have a
0.15 disutility compared with the normal category. Such disutility
in health status is similar to those who have lung cancer (0.10–
0.12) [34].
One of our key ﬁndings is that the association between EQ-5D
questionnaire indices and BMI at the time of the survey was
lower after adjusting for the weight loss. Interestingly, a study by
Klingemann et al. [35] found that compared with actual weight
achieved, weight loss is less important for quality of life. There
are some possible explanations for the difference. First, there is
an intrinsic difference in the instruments used in the studies. The
Nottingham Health Proﬁle used contains certain domains (social
isolation, energy, sleep) that do not exist in the EQ-5D question-
naire, and so it is possible that the difference in the composite
scores is due to the existence of these domains. Second, the
Klingemann et al. study is a prospective study capturing only 1
year of HRQOL data for patients after gastric bypass. Our study is
a cross-sectional design that captured retrospective BMI change
including and beyond 1 year. The difference in the ﬁnding might
be attributable to the shorter study duration of the Klingemann
et al. study. Last, Klingemann et al. reported results from gastric
bypass surgery, which is a much more invasive procedure than
LAGB. The study reported that the mean weight loss 1 year after
the surgery was 37 kg, which was much more than the 26 kg in
our study. The effectiveness and surgical complication might also
explain the difference in the ﬁndings.
Our study possesses a number of limitations that require
acknowledgment. First, the response rate of the survey was
50.8%; thus, we cannot exclude the possibility of nonresponder
bias. However, the respondents’ mean age, percentage of
females, and most importantly, the estimated 20% BMI change
weight change after LAGB were all comparable to other prospec-
tive studies [36,37]. Second, there is the possibility of recall bias,
because the presurgical weight of respondents was self-reported.
A prior study, however, showed that self-reported height and
weight measures do not differ signiﬁcantly from the actual
measured heights and weights among bariatric surgery patients
[38]. Third, we did not have patient-level data on age, a potential
confounding variable, and so we could not adjust for it in our
regression models. Fourth, we did not have EQ-5D questionnaire
data at the time of surgery to compare the relationship between
weight change and EQ-5D questionnaire change. It has been
shown, however, that the EQ-5D questionnaire is a sensitive
instrument for obesity, and there were indeed associations
between weight change and EQ-5D questionnaire changes [7].
Finally, our sample was constructed from a speciﬁc geographicalregion in the United States and results may not generalize across
the entire US population.Conclusions
The EQ-5D questionnaire has a negative and nonlinear relation-
ship with BMI for obese patients who had LAGB. The relationship
is confounded by weight loss. Within the EQ-5D questionnaire
dimensions, patients are more likely to report having problems in
the mobility, usual/activity, pain/discomfort, and anxiety/depres-
sion in higher BMI categories, but not self-care.
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